In the present study, 25 Escherichia coli strains isolated from beef, pork, and poultry meat, and producing extendedspectrum β-lactamases (ESBL) (18 strains) or AmpC-cephalosporinases (7 strains) were tested for antimicrobial resistance using the minimum inhibitory concentration method with 16 antimicrobial agents. All examined strains were resistant to ampicillin and the first-generation cephalosporins. Variable resistance to the third-generation cephalosporins (40%-100% among ESBLproducing strains and 0-72% among AmpC-producing strains) was noted. Less than 30% of examined strains were resistant to ciprofloxacin. All isolates were susceptible to the fourth-generation cephalosporins, cephalosporins connected with inhibitors of β-lactamases, carbapenems, and gentamycin.
Introduction
β-lactamases are the leading cause of resistance to β-lactam antibiotics among Gram-negative bacteria (1) . Genes encoding β-lactamases, found either in Gramnegative or Gram-positive microorganisms, are located on bacterial chromosome and on plasmids. β-lactamases can be distinguished on the basis of their nucleotide sequence homologies and differences in their ability to hydrolyse the various β-lactam antibiotics (1) . Extended spectrum β-lactamases (ESBL) and AmpC cephalosporinases, recently classified as ESBL group, are particular groups of these enzymes, discovered in the last decades of the 20 th century, and increasingly spreading among Gramnegative bacteria.
Escherichia coli is recognized as a microorganism highly capable of acquiring and transferring antimicrobial resistance genes (9, 17, 18) . A relatively frequent occurrence of β-lactamase producing E. coli in animals creates a real threat of their transfer through food to humans.
The aim of this study was to test antimicrobial resistance of ESBL-and/or AmpC-producing E. coli isolated from different kind of meat.
Material and Methods
Bacterial strains. The group of 18 ESBLproducing and 7 AmpC-producing E. coli isolated from 141 meat samples, including 78 samples of pork, 44 samples of beef, and 19 samples of poultry (Gallus gallus), was investigated. The production of β-lactamases was determined earlier by the use of disk test D68C (Mast Diagnostica, Germany), confirmatory MIC test Sensititer ® ESBL (Trek Diagnostic System, UK), and by polymerase chain reaction (PCR) as previously described (20) . (12) .
Minimum inhibitory concentration (MIC

Results
All ESBL-producing isolates showed resistance to aminopenicillin (ampicillin) and the first-generation cephalosporins (cefazolin, cephalotin). Moreover, a relatively high percentage of these strains was resistant to the third-generation cephalosporins (ceftriaxone -16 of 18 isolates, cefpodoxime, and ceftazidime -12 strains of each) ( Table 1 ). Cefotaxime and ceftazidime with clavulanic acid inhibited growth of all ESBL-producing E. coli. All these isolates were susceptible to the fourth-generation penicillin (piperacillin) connected with tazobactam. Susceptibility to the fourth-generation cephalosporin (cefepime) showed 16 of the tested ESBL-producing isolates; whereas the remaining two isolates presented MIC in the intermediate range. Five examined ESBL-positive strains were resistant to ciprofloxacin but all of them were sensitive to the second-generation cephalosporin (cefoxitin), carbapenems (imipenem, meropenem), and the aminoglycoside (gentamicin).
The AmpC-producing strains (n = 7) showed similar susceptibility as observed among ESBLproducing isolates against most antimicrobials used in the study (Table 2) . However, resistance of all these strains to the second-generation cephalosporin (cefoxitin) was observed.
None of the AmpC-positive isolates displayed resistance against two antimicrobials of the thirdgeneration cephalosporins group (ceftriaxone and cefotaxime) used in the study. On the other hand, in the case of other cephalosporins from this group (ceftazidime and cefpodoxime) one and five resistant isolates were found respectively.
The results concerning resistance of strains isolated from different meat samples to antimicrobials of the particular groups are shown in Table 3 . No significant differences in resistance/sensitivity to the first-, second-and fourth-generation cephalosporins, aminopenicillin, aminoglycoside, and carbapenems were found. However, a diversity was observed in the third-generation cephalosoprins. All ESBL-producing E. coli isolated from pork were resistant to cefpodoxime and ceftazidim; whereas some of the strains isolated from beef and poultry meat were sensitive to these antimicrobials. Similar results were found among AmpC-producing strains isolated from pork and poultry meat. On the other hand, both ESBLand AmpC-producing strains showed different resistance/susceptibility to ciprofloxacin, irrespective of the meat origin. 
Discussion
ESBL and/or AmpC-producers seem to be potentially one of the most important groups of bacteria enabling the transfer of antimicrobial resistance from animals through food chain to humans. Recently, reports confirming the presence of these strains in meat and their antimicrobial resistance have been published (2, (6) (7) (8) . The study conducted in Turkey (8) showed that all 20 ESBL-producing E. coli isolated from meat were susceptible to cefepime. Similar results were obtained in the present investigation, where 16 out of 18 such isolates were susceptible to this antimicrobial. A high percentage of E. coli susceptible to cefepime was also reported by other investigators (16); however, ESBLs are also able to confer resistance to the fourthgeneration cephalosporins (7).
The results of the present study showed resistance to ceftazidime in 66.7% of the tested strains, while Gundogan and Avci (8) reported it in less than 9% of E. coli isolated from food. On the other hand, all strains isolated from meat investigated by Arslan and Eyi (2) were susceptible to this antimicrobial. However, the analysis was performed by the disc diffusion method. In the study by Arslan and Eyi (2) , no strains resistant to the first-generation (cephazolin) and the secondgeneration (cefuroxime) cephalosoporin were found; however, almost 45% of the investigated isolates presented inhibition zones to cefuroxime in the intermediate range.
In the present study, 27.8% of ESBL-producing E. coli showed resistance to ciprofloxacin and one strain presented MIC in the intermediate range. The investigation performed in Sweden on meat imported from European countries indicated resistance to ciprofloxacin in more than 50% of E. coli carrying ESBL genes isolated from broiler meat (6), as well as in three out of seven strains recovered from beef and in one out of seven isolates of pork origin. Few of the E. coli strains carrying ESBL genes found in the Swedish investigation showed resistance to gentamycin (one isolated from poultry meat and one from beef) (6) . In the present study, none of the ESBL-producing E. coli isolates was resistant to gentamycin.
In the group of AmpC-producing strains, similarly like among ESBL-producers, all isolates were susceptible to gentamycin, which is opposite to the Swedish study, in which among 15 E. coli carrying the blaCMY-2 AmpC gene three isolates showed resistance to this antimicrobial (6) . The reason of this discrepancy may be a much lower number of AmpC-producing strains tested in the present study; however, Swedish authors also noted that in earlier European studies CMY-2 producing E. coli were found in meat samples not as frequently as in their investigations.
Six strains of AmpC-producing E. coli found in our study were sensitive to ciprofloxacin, and only one strain was resistant to this antimicrobial. Egervärn et al. (6) demonstrated such resistance more frequently (in 4 of 12 isolates) among E. coli carrying the blaCMY-2 gene isolated from poultry meat. Similarly, like in the Swedish study, the resistant strain found in the present investigation was isolated from poultry meat. Such AmpC-producing strains were not identified in beef samples in both studies.
AmpC-producing isolates examined during this study showed mainly resistance to the first-and second-generation cephalosporins. Unlike among ESBL-producers, the majority of AmpC-positive strains resistant to the third-generation cephalosporins showed resistance only to cefpodoxime. Ceftriaxone and ceftazidime inhibited growth of most of strains in the intermediate range, but in the case of cefotaxime six out of seven examined isolates were sensitive.
In the present study, E. coli isolated from meat samples of various animal species showed similar resistance/susceptibility in the case of the majority groups of antimicrobials. However, the differences were observed mainly in the third-generation cephalosporins ( Table 3) . As far as the highest occurrence of resistant strains in poultry meat was noted by many investigators from other countries before, the presence of such ESBL-producing isolates in pork was surprising (7) . None of the ESBL-positive isolates from poultry meat and beef was susceptible to ceftriaxone and cefotaxime, but strains susceptible to cefpodoxime and ceftazidime were identified.
ESBL-producing strains, initially identified mainly in hospitals, are recently more frequently isolated from the community-acquired infections (4, 10, 13-15). Furthermore, ESBL and/or AmpC positive isolates have been also recovered from meat (3, 11, 19, 21) , which may be due to the use of antimicrobial agents in food-producing animals. The present study showed that ESBL-and/or AmpC-producing E. coli of meat origin demonstrated resistance to at least two groups of antimicrobials. All of them were resistant to aminopenicillin and the first-generation cephalosporins. In the case of the third-generation cephalosporins, the resistant isolates were mainly recovered from pork and partially from poultry meat and beef. Furthermore, none of the tested strains was resistant to the fourthgeneration cephalosporins. As compared to the results of other studies (2, 6, 8) only few examined strains showed resistance to ciprofloxacin and none of them was resistant to gentamycin.
Described pilot study allowed obtaining, for the first time in Poland, data concerning antimicrobial resistance of ESBL-and/or AmpC-producing E. coli isolated from meat. Since the situation regarding the mentioned subject may change, further studies with a higher number of isolates are needed.
